A Benefit-Risk Assessment of Agomelatine in the Treatment of Major Depression Robert H. Howland Review Article 20 November 2012 Pages: 709 - 731
Safety and Tolerability Profiles of Anticholinergic Agents Used for the Treatment of Overactive Bladder Michael G. Oefelein Review Article 20 November 2012 Pages: 733 - 754
Effectiveness of Pharmacovigilance Training of General Practitioners Roald GerritsenHans FaddegonEugène van Puijenbroek Original Research Article 20 November 2012 Pages: 755 - 762
Psychiatric Adverse Events Associated with Varenicline Mira Harrison-WoolrychJanelle Ashton Original Research Article 20 November 2012 Pages: 763 - 772
Mortality in Children and Adolescents Prescribed Antipsychotic Medication Fariz A. RaniPatrick ByrneIan C.K. Wong Original Research Article 20 November 2012 Pages: 773 - 781
Randomized Controlled Trials of COX-2 Inhibitors Gudrun StefansdottirMarie L. De BruinHubert G.M. Leufkens Original Research Article 20 November 2012 Pages: 783 - 792
Can Social Media Benefit Drug Safety? Willibert Franzen Correspondence 20 November 2012 Pages: 793 - 793